Know Cancer

or
forgot password

Effect of Conjugated Linoleic Acid Alone and in Conjunction With Vitamin E on Insulin Sensitivity, Beta Cell Function, Markers of Inflammation, Body Fat Mass and Other Biochemical Indicators in Patients With Type 2 Diabetes Mellitus


N/A
30 Years
70 Years
Not Enrolling
Both
Type 2 Diabetes Mellitus

Thank you

Trial Information

Effect of Conjugated Linoleic Acid Alone and in Conjunction With Vitamin E on Insulin Sensitivity, Beta Cell Function, Markers of Inflammation, Body Fat Mass and Other Biochemical Indicators in Patients With Type 2 Diabetes Mellitus


Inclusion Criteria:



- Diagnosis of type 2 diabetes mellitus > 5 years

- HbA1c ≤ 9%

- Overweight or obese (BMI ≥ 25 kg/m2 and ≤ 30 kg/m2)

- Age ≥ 30 and ≤ 70 years (postmenopausal if female)

- Stable medical therapy for past 3 months

- Stable serum glucose for past 3 months (128-180 mg/Dl)

- Age between 30 to 50

- Use of metformin

- TG < 240 mg/Dl

- No alcohol, no insulin, no smoke

- No pregnancy, no menopause

Exclusion Criteria:

- Personal history of coronary heart disease

- Cerebrovascular disease or vascular disease

- Renal or hepatic disease

- Inflammatory diseases and thyroid diseases within the last years

- Use of drugs known to affect glycemic control, beta blockers, any change in daily
activity profile, and diet

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Outcome Measure:

insulin sensitivity

Safety Issue:

No

Authority:

Iran: Ministry of Health

Study ID:

2387

NCT ID:

NCT01099163

Start Date:

January 2009

Completion Date:

October 2010

Related Keywords:

  • Type 2 Diabetes Mellitus
  • Diabetes mellitus
  • CLA
  • Antioxidant
  • Glycemic control
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2

Name

Location